Mounjaro Weight Loss Jab Price Slashed in UK
Eli Lilly drastically cuts the price of its Mounjaro injection in the UK, making the revolutionary diabetes and weight loss treatment more accessible. The move follows a landmark NHS supply deal.
Eli Lilly drastically cuts the price of its Mounjaro injection in the UK, making the revolutionary diabetes and weight loss treatment more accessible. The move follows a landmark NHS supply deal.
The UK's medicines watchdog approves the weight loss injection Mounjaro (tirzepatide), offering a powerful new option in the fight against obesity. Discover its price, how it works, and where to get it.
Eli Lilly suspends shipments of obesity drug Mounjaro to the UK, triggering a major price surge and leaving thousands of patients in limbo amid supply chain restructuring.
NHS England deploys a unique team of 'people experts' to hospitals in South London to manage severe winter pressures, patient flow, and staff welfare during a major incident.
Exclusive analysis reveals a dramatic surge in Britons turning to private medical care, driven by unprecedented NHS waiting times and a perceived 'postcode lottery' for treatment. This investigation uncovers the human cost of the healthcare crisis.
Exclusive investigation reveals a record number of young children, some just three years old, are being referred to specialist obesity services amid a growing national health emergency.
A British woman's life-changing weight loss journey using Mounjaro injections has been thrown into turmoil after a dramatic price increase made the drug unaffordable, forcing her to confront the return of debilitating 'food noise'.
A British mother who lost seven stone on diabetes drug Mounjaro issues urgent health warning after suffering severe side effects including vomiting brown liquid and excruciating stomach pain.
A damning new report reveals UK supermarkets are making healthy food up to twice as expensive as unhealthy alternatives through aggressive promotions, disproportionately harming low-income families.
The NHS launches its most significant diabetes care reform in a decade, offering Ozempic-style injections to thousands in a bid to tackle obesity-driven type 2 cases and potentially slash future complications.
New research suggests that popular weight loss injections may lead to rebound weight gain, raising concerns among health professionals.
Patients relying on Mounjaro for weight loss face financial strain as prices skyrocket. Experts reveal the alarming consequences of this sudden hike.
The UK approves Mounjaro, a groundbreaking weight loss injection, but concerns over its £300 monthly price tag spark debate over NHS accessibility.
The diabetes drug Ozempic is making waves as a weight-loss solution, but experts urge caution. Discover the pros, cons, and science behind the trend.
A man who once weighed a staggering 51 stone shares his incredible weight loss journey, revealing the struggles and triumphs of battling obesity.
The NHS is set to trial the weight loss injection Mounjaro, a drug hailed as a potential game-changer in obesity treatment, as part of a new pilot programme targeting adults struggling with weight issues.
New NHS weight loss injections, including Mounjaro, are being rolled out unevenly, creating a 'postcode lottery' for patients struggling with obesity.
New research suggests that weight loss injections like Wegovy may lead to significant weight regain once discontinued, raising concerns about long-term effectiveness.
The NHS is expanding access to obesity treatments Mounjaro and Wegovy, making them available in local pharmacies following approval by NICE.
New research warns that patients who stop taking weight-loss injections like Wegovy may regain most of the lost weight, raising concerns about long-term effectiveness.
New research reveals the surprising long-term benefits of weight loss injections like Mounjaro and Ozempic, offering hope for sustainable obesity management.
A recent report highlights severe staffing shortages within the NHS, raising concerns over patient care and service sustainability. Experts warn of growing pressures on healthcare workers.
UK pharmacists raise alarms over the skyrocketing demand for weight-loss medications, calling it unsustainable and urging for systemic changes.
A groundbreaking DNA test may soon help identify children at risk of obesity early, offering parents and doctors a chance to intervene before health issues arise.
A groundbreaking AI-powered tool can now predict childhood obesity with high accuracy, offering early intervention opportunities to combat the growing health crisis.
Five deaths in Scotland have been linked to popular weight-loss injections, prompting calls for an urgent safety review. Experts warn of potential risks as demand for these treatments soars.
New research reveals that weight loss injections like Mounjaro and Wegovy are proving highly effective for Generation X, offering hope in the battle against obesity.
Experts warn that two widely used weight loss injections may face restrictions in the UK due to safety concerns. Here’s the latest on the potential ban and alternatives.
UK doctors are striking once more over pay and working conditions, deepening the NHS crisis. Here’s why they’re walking out and what it means for patients.
The NHS is set to provide Wegovy and Mounjaro, groundbreaking weight-loss medications, following new evidence of their health benefits beyond obesity treatment.